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never drove (ND), non-drivers who gave up driving because of eyesight (GDE), and
non-drivers who gave up driving because of other reasons (GDO). We performed
analysis of variance to estimate differences among different driving statuses for the 
HU and all QOL scores. Least squares means adjusted on bilateral VA, age, gender,
and country were calculated. RESULTS: ND group reported signiﬁ cantly lower HU 
than D group (p  0.0006). Seven out of 10 vision functioning scores, general health 
score, and composite score of ND group were also lower than D group (p  0.05). 
GDE showed lower mean scores for all the QOL dimensions when compared to D 
group while GDO had no difference. Patients with better WEVA (BEVA  20/40:
WEVAq20/200) reported higher scores on the NEI-VFQ 25 dimensions of dependency, 
near vision, and driving as well as the composite scores than patients with worse
WEVA (BEVA  20/40:WEVA  20/200) (p  0.05). CONCLUSIONS: The results of 
bilateral visual acuity show different impacts on vision functioning. When BEVA falls 
below 20/40, WEVA severity resulted in higher burdens on overall vision related QOL
as well as dependency and near vision functioning. Driving status is shown to be sig-
niﬁ cantly associated with QOL. Physicians should be aware of driving status when 
evaluating QOL in patients with NV-ARMD.
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LINGUISTIC VALIDATION OF THE ATTENTION AND 
PERFORMANCE SELF-ASSESSMENT SCALE, APSA, FOR USE
IN INTERNATIONAL STUDIES
Montigny C1, Görtelmeyer FR2, Korbel US2
1Mapi Research Institute, Lyon, France, 2MERZ Pharmaceuticals GmbH, Frankfurt am Main, 
Germany
OBJECTIVES: To assess the patient-reported ability to concentrate of people with 
tinnitus in an international context, the 30-item APSA originally developed in German 
had to be translated into 5 languages. A rigorous methodology was employed to ensure 
conceptual equivalence and cross-cultural relevance of the translations. METHODS:
To facilitate the translation process, the original German version was ﬁ rst translated 
into US English and then into the 5 target languages following the internationally 
accepted process: 1) forward translation; 2) back translation; 3) clinician review; 4) 
cognitive debrieﬁ ng on 5 patients with tinnitus; and 5) international harmonization. 
Each step was conducted in close collaboration with the developer. RESULTS: two 
challenges were inherent in this process: (1) For reasons of timing, the translations
into languages other than English started prior to ﬁ nalizing the US version. This 
interpretation of the US English text as a non-ﬁ nal interpretation of the German
original required a constant update of the list of concepts (the document deﬁ ning the 
meaning of each item and accepted alternative formulations for translations) as well
as a constant modiﬁ cation of the US English translation and consequently the other 
language versions. (2) The “two wave” translation process revealed issues in the
German original requiring the integration of updates at all levels as well as the refor-
mulation of 2 items in the German version. CONCLUSIONS: The translation of the 
APSA was performed following a rigorous methodology to facilitate international 
comparison and pooling of data. The project demonstrates the difﬁ culty of using 
non-English measures in an international context. It also reveals the essential role the 
“list of concepts” plays in the translation process and suggests the advantage of inte-
grating international input into the design of measures when these are used in an 
international context.
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DEVELOPMENT AND VALIDATION OF PATIENT-REPORTED
OUTCOMES (PRO) TOOL FOR EYELASH CHARACTERISTICS
Hammond GC1, Burgess SM2, Cole JC1, Yang M1, Hansen JE2, Walt JG2
1QualityMetric Health Outcome Solutions, Lincoln, RI, USA, 2Allergan, Inc., Irvine, CA, USA
OBJECTIVES: The development and validation of a PRO tool identifying and measur-
ing domains of interest in eyelash characteristics. METHODS: Development of the 
conceptual framework and candidate questions was based on subject focus groups 
followed by clinician feedback. Psychometric assessment of the item- and scale-level 
reliability and validity was undertaken on a non-treated, cross-sectional convenience 
sample of female participants using two methods of administration (68 paper version
and 924 web-based). Conﬁ rmatory factor analysis, alpha statistics, convergent and 
discriminant validity were calculated to assess overall model ﬁ t. Model ﬁ t was also 
assessed in a sample receiving Latisse (bimatoprost), a prescription treatment thought
to increase the length, thickness, and darkness of eyelashes (n  277). RESULTS: Three 
conceptual domains were identiﬁ ed in four focus groups conducted in various areas 
of the U.S. with women of different ages. Physician feedback conﬁ rmed and reﬁ ned 
the three conceptual domains: satisfaction with physical eyelash attributes (length, 
fullness, overall satisfaction); subjective feelings attributed to eyelash satisfaction 
(conﬁ dence, attractiveness, looking professional); and daily routine in making eye-
lashes presentable. The ﬁ nalized questionnaire structure (nine questions over three 
domains) showed good overall model ﬁ t characteristics on the non-clinical population
(x2(24)  62.9, Comparative Fit Index (CFI):0.99, Root Mean Square Error of Approx-
imation (RMSEA) [90% CI]:0.05 [0.04–0.06]). Item-total correlations ranged from 
0.55 to 0.88, with most over 0.60, indicating a large effect size. Internal consistency
ranged from 0.92 to 0.98 for the three domains. Convergent validity was signiﬁ cantly
higher than discriminant validity for these domains. No differential item functioning
between methods of administration was observed. Similar ﬁ t statistics were observed
in the clinical sample. CONCLUSIONS: The multi-step development and validation 
processes identiﬁ ed a three-domain conceptual framework. This was also validated by
psychometric assessment of the questionnaire properties in both a convenience sample
and one receiving the prescription treatment.
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THE RELATIONSHIP BETWEEN SATISFACTION WITH VISION AND 
SPECTACLE INDEPENDENCE
Waycaster C
Alcon Laboratories Inc, Fort Worth, TX, USA
OBJECTIVES: The objective of this study was to determine the relationship between 
satisfaction with vision and spectacle independence in cataract patients bilaterally 
implanted with a presbyopia correcting intraocular lens (IOL). METHODS: This 
study was based on a prospective multi-center US clinical trial of cataract patients 
bilaterally implanted with the presbyopia correcting AcrySof ReSTOR Aspheric 3.0 
diopter add power lens (model SN6AD1 Alcon Labs Fort Worth, Texas). Spectacle 
independence and satisfaction with vision data were collected using the Cataract TyPE 
questionnaire (TyPE). The TyPE is a reliable, valid questionnaire designed to assess 
cataract patient functional status and quality-of-life. The TyPE was administered pre-
operatively and 6 months after the second eye surgery. Spectacle independence was 
assessed using a 3 point scale with 1 anchored at always wear glasses and 3 anchored 
at never wear glasses. Spectacle independence is deﬁ ned as never wearing glasses.
Satisfaction with vision was assessed using a 5 point scale with 0 anchored at not at
all satisﬁ ed and 4 anchored at completely satisﬁ ed. The relationship between the
spectacle independence and satisfaction with vision was assessed using Spearman’s 
Rho statistic and a simple linear regression. RESULTS: One hundred and thirty eight 
SN6AD1 recipients completed the TyPE both preoperatively and 6 months after 
second eye implantation. Preoperatively, only 2% of the patients indicated spectacle
independence compared to 78% postoperatively. Satisfaction with vision improved
from 0.5 at baseline to 3.3 postoperatively. There was a signiﬁ cant (p  0.0001) cor-
relation between spectacle independence and satisfaction with vision (Spearman’s Rho 
 0.48). The relationship between the spectacle independence and satisfaction can be
expressed using the following linear equation: Satisfaction change  1.38  1.01* 
Spectacle Independence change. R-squared for the linear model was calculated at 0.29. 
CONCLUSIONS: According to this research, the less cataract patients relied on their 
glasses, the greater their satisfaction with their vision.
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DISEASE BURDEN AND PRODUCTIVITY LOSS IN A CANADIAN
ONLINE SURVEY POPULATION OF INDIVIDUALS WITH
MODERATE-TO-SEVERE PLAQUE PSORIASIS
Papp K1, Wasel N2, Poulin Y3, Chan D4, Fraquelli E4, Andrew R4
1K. Papp Clinical Research, Probity Medical Research, Waterloo, ON, Canada, 2Stratica
Medical, Edmonton, AB, Canada, 3Laval University and Centre Dermatologique du Quebec
Metropolitain, Quebec City, QC, Canada, 4Janssen-Ortho, Inc., Toronto, ON, Canada
OBJECTIVES: Psoriasis is a chronic autoimmune disorder associated with substantial 
psychological, social and economic burden. The present study investigated the burden 
of moderate-to-severe plaque type psoriasis on the occupational function and produc-
tivity in a Canadian population. METHODS: An online survey was conducted using 
a Canadian consumer panel. Eligible respondents reported a diagnosis of psoriasis by 
a physician, had at least moderate disease within the past 5 years and met at least one 
of the following criteria: 1) body surface area affected q3%; 2) psoriasis on a sensitive 
area of the body (i.e. hands, feet, scalp, face, or genitals); or 3) currently from the
receiving prescription oral and/or injectable medication or phototherapy for their 
psoriasis. RESULTS: A total of 514 of 3845 panelists that were eligible to participate
completed the questionnaire. Mean age of respondents was 49.7 years, with a male
to female ratio of 1:2. The majority of respondents (65%) reported moderate, severe 
or very severe psoriasis at the time of the survey. In the week prior to the survey, 28%
reported that their skin had been either ‘very much’ or ‘a lot’ of a problem when at 
work or while studying. A lower mean household income was associated with “moder-
ate or more severe” psoriasis ($59,550) compared with “very mild/mild” disease 
($68,450). Career prospects were negatively affected in 24% of respondents and this
increased with disease severity. Sleep disturbance due to psoriasis was reported to have 
a minimum of “some impact” on performance throughout the day in almost half of 
all respondents (48%). CONCLUSIONS: The burden of psoriasis in a large sample 
of Canadians reporting moderate-to-severe disease extends to the workplace and 
is associated with limitations in occupational function and challenges to career 
prospects.
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PHYSICIANS’ AWARENESS, ATTITUDE, AND BEHAVIOR TO USE THE
WAIT AND WATCH APPROACH FOR THE TREATMENT OF ACUTE
OTITIS MEDIA
Donga PZ1, Goyal RK2, Sansgiry SS2
1Abt Bio-Pharma Solutions, Inc., Lexington, MA, USA, 2University of Houston, Houston, TX, 
USA
OBJECTIVES: A recent guideline issued by the American Academy of Pediatricians
(AAP) recommends to use the wait and watch approach for the treatment of acute otitis
media (AOM). The objective of this study was to assess the relation between physicians’
awareness, attitude and behavior to use the wait and watch approach for the treatment
of AOM. METHODS: A cross-sectional survey based study was conducted. The 
sample for the study included physicians in the Houston area. A list of pediatricians
and family practitioners was obtained from the Yellow Pages. Physicians were 
Abstracts A79
approached on a one-to-one basis and were requested to participate in the study. A 
previously validated survey instrument that measured awareness, attitude and behavior
towards the wait and watch approach was used. Data were coded and analyzed using
SAS 9.1 to perform descriptive statistics and stepwise multivariate linear regression. 
RESULTS: A total of 89 completed surveys were collected with a response rate of 
22.25%. Majority of the respondents were pediatricians (75%), while 19.32% were 
family practitioners. About 44% of the physicians were aware and familiar with the 
wait and watch approach recommendation from the AAP guideline. In general, physi-
cians had a positive attitude towards the wait and watch approach (3.99 o 0.78). Physi-
cians in this sample reported that they sometimes used the wait and watch approach in
patients q2 years (2.83 o 0.86). Awareness (B  0.256) and attitude (B  0.32) were 
found to be signiﬁ cantly associated with behavior (p  0.05) when controlled for
demographic and decision-making factors in the multivariate regression model. CON-
CLUSIONS: Awareness regarding the wait and watch approach leads to positive atti-
tude that ultimately leads to behavior to use the wait and watch approach. Increased 
use of this approach may reduce antibiotic costs and resistance issues substantially.
Further research on a national sample is needed to validate the study results.
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PHP2
PHARMACY BENEFIT DESIGN AND PATIENT DRUG SUBSTITUTION
Shang B
The Urban Institute, Washington, DC, USA
OBJECTIVES: This paper 1) examines the extent of drug substitution, for example, 
from brand-name drugs to generic drugs and from retail order to mail order; 2) simu-
lates the cost savings associated with drug substitution; and 3) estimates the effects of 
various factors on drug substitution, including patient characteristics, cost sharing and 
generic entry. METHODS: We use pharmacy claims data from three employers for 
working-aged adults and their dependents from 1998 to 2004. We focus on ﬁ ve major
therapeutic classes and track the share of total days supplied of each therapeutic class 
in six categories: generic and retail, multi-source brand and retail, single-source brand 
and retail, generic and mail order, multi-source brand and mail order, single-source
brand and mail order. The shares are compared by drug plan over time and we simu-
late the cost savings (both total costs and OOP costs) by assuming these shares are
ﬁ xed at the 1998 level through the rest of the study period. RESULTS: Per capita drug 
spending is 10%, 12% and 2% lower, respectively, for each plan in 2003 than it would
have been had no substitution occurred since 1998. We ﬁ nd substantial variation in
substitution by therapeutic class, by drug plan and over time. Plan 1 realized the most 
savings from Histamine (H2) Antagonist (185% for Plan 1, 11% for Plan 2 and 45% 
for Plan 3) while Plan 2 realized the most savings from Cardiac, ACE Inhibitors (56%
for Plan 1, 76% for Plan 2 and 23% for Plan 3). Savings on OOP costs vary as well. 
CONCLUSIONS: Drug substitution could result in substantial savings. To more 
effectively promote drug substitution, certain policy steps need to be taken to address 
factors other than cost sharing, such as physician prescribing behaviors.
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HEALTH CARE PATTERNS AND PATIENT SATISFACTION 
IN EUROPE: A COMPARISON OF SIX COUNTRIES
Narayanan S1, Potthoff P2, Guether B2
1TNS Healthcare, New York, NY, USA, 2TNS Healthcare, Munich, Bavaria, Germany
OBJECTIVES: To assess health care patterns and patient satisfaction with health care
systems among six European nations. METHODS: TNS European Healthcare Panel 
of individuals in France, Germany, Italy, Spain, UK and the Netherlands were surveyed
in 2007 to assess health care patterns and disease burden at national level. The data
is representative of population gender and age in respective countries, ensured by 
sampling and intensive panel management. The survey collected information on health 
conditions, quality of life, health care-utilization and satisfaction with health care 
system. RESULTS: Approximately 175,000 individuals completed the survey, with 
equal male/female representation. Pain(83,300), Allergy(53,100), Migraine(38,400),
Sleeping problems(35,900), Skin-disease(35,800), Gastrointestinal-disease(34,000), 
Depression(31,200), High blood-pressure(22,800), Urinary-problems(20,200) 
and High-cholesterol(19,200) were the top-10 reported ailments. Across the
countries, 49.9% self-diagnosed a health condition (range: 37.5%(Netherlands)
to 59.5%(Germany)), whereas 13.3% (range: 8.4%(Italy) to 19.1%(Netherlands)) 
and 19.4% (range: 8.8%(UK) to 24.7%(Germany)) reported Primary Care Physician
and Specialist as primary source of diagnosis. Correspondingly, 34.3% (range:
20.1%(Spain) to 59.0%(UK)) reported self-medication, while 26.3% (range:
20.7%(Italy) to 34.1%(France)), 28.8% (range: 8.1%(UK) to 41.2%(France)) and
6.3% (range: 3.8%(Netherlands) to 11.6%(Italy) reported being treated by Primary 
Care Physician/Specialist/Hospital Clinic respectively. Overall, 71.6% (range: 
57.6%(UK) to 82.4%(France)), 36.0% (range: 23.6%(Spain) to 58.5%(UK)), 12.9% 
(range: 3.7%(Netherlands) to 17.7%(France)), 5.4% (range: 2.8%(Netherlands) to
7.5%(UK)) and 9.1% (range: 7.7%(Italy) to 12.3%(UK)) were treated with prescrip-
tion-medications, OTC, plant-based-pharmaceuticals, alternative-therapeutic-options, 
and other products respectively. Satisfaction with health care-system varied dramati-
cally: 49% very-satisﬁ ed/satisﬁ ed (range: 26%(Italy) to 66%(France)); 17% Neutral
(range: 7%(France/Netherlands) to 27%(Italy)) and 34% somewhat/very-dissatisﬁ ed
(range: 27%(France) to 47%(Italy)). CONCLUSIONS: Patient satisfaction with health 
care system appears to be low and reports of self-diagnosis and self-medication are
high in the countries. This highlights the increasing importance of patient involvement 
in health care and treatment and need for integrating patients into health care pro-
cesses in various forms to alleviate health care burden (clinical/economic/humanistic) 
in respective geographies.
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CHANGES OF THE CASE-MIX INDEX OF THE HUNGARIAN
INTENSIVE CARE UNITS
Varga S1, Bogár L1, Sebestyén A2, Vas G1, Ágoston I1, Kriszbacher I1, Boncz I3
1University of Pécs, Pecs, Hungary, 2National Health Insurance Fund Administration, Budapest, 
Hungary, 3University of Pécs, Pécs, Hungary
OBJECTIVES: Diagnosis-related Group (DRG) classiﬁ cation as a normative health 
ﬁ nancing system, has been used by the National Health Insurance Fund Administra-
tion (NHIFA) in Hungary since 1993. In the intensive care in our DRG system it can
frequently occur that real cost exceed the reimbursement. In the view of the intensive 
care, the case mix index (CMI) correlate the reimbursement. A 10 years run of the 
CMI was analyzed comparing the global mean CMI of all recognized specialties to
the mean CMI of the intensive therapy. METHODS: Using the data of the NHIFA 
between 1995 and 2005, the CMI of the intensive therapy treatment was compared 
to the mean CMI of all recognized medical specialties. RESULTS: The case-mix index 
of intensive care units increased from 1.69 in 1995 to 4.79 in 2005, while the average 
case-mix index of all medical specialties increased moderately from 1.08 in 1995 to
1.11 in 2005. In the ﬁ rst two years, in 1995 and in 1996, the CMI of the intensive
therapy was 56% more than the global mean. But in 1997, a sudden great increase
happened to 165% and after that to 197% in 1998 and ﬁ nally to 250% in 1999. 
From the year 2000, the rise of CMI was between 1.5% and 22.8% from year to year 
increasing to 333%. During these 10 years, the changing of the global mean CMI of 
the all specialties was only 2.5%. CONCLUSIONS: In Hungary between 1995 and 
2005, while the CMI of all recognized specialties increased only 2.5%, the biggest 
change happened in the intensive specialty. The CMI increased from 1.6 to 4.8 weight-
number which means a 300% rise. During this time, the reimbursement of one 
weight-number runs high too.
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MARKET SHARE OF INTENSIVE CARE UNITS IN HUNGARY
ACCORDING TO THE DRG SYSTEM
Varga S1, Bogár L1, Sebestyén A2, Nagy Z3, Ágoston I1, Kriszbacher I1, Boncz I4
1University of Pécs, Pecs, Hungary, 2National Health Insurance Fund Administration, Budapest, 
Hungary, 3Health Insurance Supervisory Authority, Budapest, Hungary, 4University of Pécs, 
Pécs, Hungary
OBJECTIVES: The reimbursement of one patient therapy is always disputed as is 
questioned the exactness of the cost calculation. The goal of our analysis was to deﬁ ne
the change of market share in the reimbursement compared to the change in amount
of patients in intensive therapy in the period between 1995 and 2005 in Hungary.
METHODS: Diagnosis-related Groups (DRG) classiﬁ cation as a normative health
ﬁ nancing system has been used in Hungary since 1993. Data of the analysis was taken 
from the ﬁ nancial database of the Hungarian National Health Insurance Fund Admin-
istration covering the period 1995–2005. RESULTS: In the intensive therapy, the
patient number rate of all in-patient care was 0.75% in 1995. During four years, it
increased slowly. In 1998 it was 0.87%. In 1999 a sudden increase happened, the rate
reached 1.33%, and after that it consistently went up to 1.67% in the last 5 years. 
Comparing 2005 to 1995, the total rise was 123% in number of patients treated in
intensive care units. Using the DRG weight-number as a base value for ﬁ nancing the 
market share, the reimbursement of the intensive therapy was 1.2–1.3% in 1995–
1996, and after that increased to 2.2–2.6% in 1997–1998 and to 4.6% in 1999. From
2000 to 2005 the increase was gradual but progressive. In 2005 the market share of 
the intensive therapy was 7.2%, which (6.2 times more then in 1995). The total change 
was 516%. CONCLUSIONS: While the number of the treated patients increased
123%, the rise of the reimbursement was 516%. So the ﬁ nancing of the intensive 
therapy changed positively between 1995 and 2005 in Hungary.
HEALTH CARE USE & POLICY STUDIES – Drug/Device/Diagnostic
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PHYSICIAN KNOWLEDGE OF THE FDA-APPROVED INDICATIONS OF
COMMONLY PRESCRIBED DRUGS: RESULTS OF A NATIONAL SURVEY
Moloney R1, Chen D2, Wynia MK3, Alexander GC1
1University of Chicago, Chicago, IL, USA, 2University of Virginia, Charlottesville, VA, USA, 
3American Medical Association, Chicago, IL, USA
OBJECTIVES: The Food and Drug Administration (FDA) regulates prescription drug
marketing, not prescribing, and medication use for non-FDA approved indications 
(“off-label use”) is common. However, many off-label uses lack supporting evidence
and may expose patients to unwarranted risk. We sought to determine physicians’
